The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome
Objective: Postoperative radiotherapy for early endometrial cancer has been investigated in several randomized trials. These trials demonstrate that it reduces loco-regional recurrence, but has no impact on overall survival. The aims of this study were to better understand the role of adjuvant radio...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Taiwanese Journal of Obstetrics & Gynecology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455919301603 |
_version_ | 1819168389164171264 |
---|---|
author | Yu-Jung Lin Yu-Wen Hu Nae-Fang Twu Yu-Ming Liu |
author_facet | Yu-Jung Lin Yu-Wen Hu Nae-Fang Twu Yu-Ming Liu |
author_sort | Yu-Jung Lin |
collection | DOAJ |
description | Objective: Postoperative radiotherapy for early endometrial cancer has been investigated in several randomized trials. These trials demonstrate that it reduces loco-regional recurrence, but has no impact on overall survival. The aims of this study were to better understand the role of adjuvant radiotherapy and determine predictors for loco-regional recurrence or development of distant metastasis. Materials and methods: A retrospective medical records review was performed on patients with surgical stage I endometrial cancer treated at Taipei Veterans General Hospital between 2006 and 2013. Multivariable analysis was conducted using Cox regression for prognostic predictors. Results: A total of 337 patients were identified. The estimated five-year overall survival and loco-regional recurrence-free survival were 96.3% and 97.9% in the non-radiotherapy group, and 91.6% and 97.1% in the radiotherapy group (p = 0.06 overall survival, p = 0.956 loco-regional recurrence-free survival). Multivariable analysis revealed that elevated preoperative serum Cancer Antigen 125 (CA-125) level (hazard ratio (HR) = 2.54), age older than 60 years old (HR = 3.34), and depth of myometrial invasion > 50% (HR = 3.37) were significant factors in overall survival. Elevated preoperative CA-125 level (HR = 5.37), age older than 60 years (HR = 6.57), positive lymphovascular space invasion (HR = 50.20), and adjuvant radiotherapy (HR = 0.05) were independent predictors of loco-regional recurrence-free survival. For distant metastasis, deep myometrial invasion was a significant risk factor. Conclusions: Postoperative radiotherapy delivery is an independent predictor for loco-regional recurrence-free survival but has no impact on overall survival in this population. Preoperative CA-125 level is a risk factor for loco-regional recurrence, and deep myometrial invasion was correlated with distant metastasis. Keywords: Endometrial neoplasms, Radiotherapy, Adjuvant |
first_indexed | 2024-12-22T19:02:49Z |
format | Article |
id | doaj.art-3f5bed305dbb491fa42d848064b85dcb |
institution | Directory Open Access Journal |
issn | 1028-4559 |
language | English |
last_indexed | 2024-12-22T19:02:49Z |
publishDate | 2019-09-01 |
publisher | Elsevier |
record_format | Article |
series | Taiwanese Journal of Obstetrics & Gynecology |
spelling | doaj.art-3f5bed305dbb491fa42d848064b85dcb2022-12-21T18:15:53ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592019-09-01585604609The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcomeYu-Jung Lin0Yu-Wen Hu1Nae-Fang Twu2Yu-Ming Liu3Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC; National Yang-Ming University, Taipei, Taiwan, ROCDivision of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei City, Taiwan, ROCDepartment of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taiwan, ROCDivision of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC; National Yang-Ming University, Taipei, Taiwan, ROC; Corresponding author. Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, No. 201, Sec.2, Shipai Rd., Taipei City, 11217, Taiwan, ROC. Fax: +886 2 28749425.Objective: Postoperative radiotherapy for early endometrial cancer has been investigated in several randomized trials. These trials demonstrate that it reduces loco-regional recurrence, but has no impact on overall survival. The aims of this study were to better understand the role of adjuvant radiotherapy and determine predictors for loco-regional recurrence or development of distant metastasis. Materials and methods: A retrospective medical records review was performed on patients with surgical stage I endometrial cancer treated at Taipei Veterans General Hospital between 2006 and 2013. Multivariable analysis was conducted using Cox regression for prognostic predictors. Results: A total of 337 patients were identified. The estimated five-year overall survival and loco-regional recurrence-free survival were 96.3% and 97.9% in the non-radiotherapy group, and 91.6% and 97.1% in the radiotherapy group (p = 0.06 overall survival, p = 0.956 loco-regional recurrence-free survival). Multivariable analysis revealed that elevated preoperative serum Cancer Antigen 125 (CA-125) level (hazard ratio (HR) = 2.54), age older than 60 years old (HR = 3.34), and depth of myometrial invasion > 50% (HR = 3.37) were significant factors in overall survival. Elevated preoperative CA-125 level (HR = 5.37), age older than 60 years (HR = 6.57), positive lymphovascular space invasion (HR = 50.20), and adjuvant radiotherapy (HR = 0.05) were independent predictors of loco-regional recurrence-free survival. For distant metastasis, deep myometrial invasion was a significant risk factor. Conclusions: Postoperative radiotherapy delivery is an independent predictor for loco-regional recurrence-free survival but has no impact on overall survival in this population. Preoperative CA-125 level is a risk factor for loco-regional recurrence, and deep myometrial invasion was correlated with distant metastasis. Keywords: Endometrial neoplasms, Radiotherapy, Adjuvanthttp://www.sciencedirect.com/science/article/pii/S1028455919301603 |
spellingShingle | Yu-Jung Lin Yu-Wen Hu Nae-Fang Twu Yu-Ming Liu The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome Taiwanese Journal of Obstetrics & Gynecology |
title | The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome |
title_full | The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome |
title_fullStr | The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome |
title_full_unstemmed | The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome |
title_short | The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome |
title_sort | role of adjuvant radiotherapy in stage i endometrial cancer a single institution outcome |
url | http://www.sciencedirect.com/science/article/pii/S1028455919301603 |
work_keys_str_mv | AT yujunglin theroleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome AT yuwenhu theroleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome AT naefangtwu theroleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome AT yumingliu theroleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome AT yujunglin roleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome AT yuwenhu roleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome AT naefangtwu roleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome AT yumingliu roleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome |